Positioning ustekinumab in Crohn's disease: from clinical evidence to clinical practice.

about

Ustekinumab use in Crohn's disease: a Canadian tertiary care centre experience.Clinical utility of ustekinumab in Crohn's disease.

P2860

Q48014899-9ECA93DB-B758-4A41-8827-908C04CC124E Q49218809-1269F78D-6EF3-47EF-B584-7A5C40B657EC

P2860

Positioning ustekinumab in Crohn's disease: from clinical evidence to clinical practice.

Item

http://www.wikidata.org/entity/Q38748380

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Positioning ustekinumab in Crohn's disease: from clinical evidence to clinical practice.

@en

type

Item

label

Positioning ustekinumab in Crohn's disease: from clinical evidence to clinical practice.

@en

prefLabel

Positioning ustekinumab in Crohn's disease: from clinical evidence to clinical practice.

@en

P1476

Positioning ustekinumab in Crohn's disease: from clinical evidence to clinical practice.

@en

P2093

Silvio Danese

http://www.w3.org/2001/XMLSchema#string

Stefanos Bonovas

http://www.w3.org/2001/XMLSchema#string

P2860

Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease

Characterizing unmet medical need and the potential role of new biologic treatment options in patients with ulcerative colitis and Crohn's disease: a systematic review and clinician surveys

IL-23 promotes tumour incidence and growth

Modulation of CLA, IL-12R, CD40L, and IL-2Ralpha expression and inhibition of IL-12- and IL-23-induced cytokine secretion by CNTO 1275

Infliximab maintenance therapy for fistulizing Crohn's disease

Interleukin-12 and Th1 immune response in Crohn's disease: pathogenetic relevance and therapeutic implication

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene

Anti-interleukin-12 antibody for active Crohn's disease

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis.

P31

scholarly article

P356

10.1093/ECCO-JCC/JJX079

http://www.w3.org/2001/XMLSchema#string

P50

Laurent Peyrin-Biroulet

P577

2017-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28575273

http://www.w3.org/2001/XMLSchema#string

Positioning ustekinumab in Crohn's disease: from clinical evidence to clinical practice.

about

P2860

P2860

Positioning ustekinumab in Crohn's disease: from clinical evidence to clinical practice.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P31

P356

P50

P577

P698